Activation of human peroxisome proliferator-activated receptor (PPAR) subtypes by pioglitazone.

PubWeight™: 1.43‹?› | Rank: Top 5%

🔗 View Article (PMID 11095972)

Published in Biochem Biophys Res Commun on November 30, 2000

Authors

J Sakamoto1, H Kimura, S Moriyama, H Odaka, Y Momose, Y Sugiyama, H Sawada

Author Affiliations

1: Discovery Research Laboratories IV, Takeda Chemical Industries, Ltd., Osaka, Japan.

Articles citing this

PPARγ signaling and metabolism: the good, the bad and the future. Nat Med (2013) 3.71

Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists. Front Biosci (2008) 1.88

The peroxisome proliferator-activated receptor-gamma agonist pioglitazone represses inflammation in a peroxisome proliferator-activated receptor-alpha-dependent manner in vitro and in vivo in mice. J Am Coll Cardiol (2008) 1.81

The Concise Guide to PHARMACOLOGY 2013/14: nuclear hormone receptors. Br J Pharmacol (2013) 1.70

PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis. Circ Res (2002) 1.66

The role of mitochondria in the pathophysiology of skeletal muscle insulin resistance. Endocr Rev (2009) 1.57

Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes. Cell Metab (2014) 1.53

Effects of the PPARgamma agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus. J Clin Invest (2005) 1.49

Selective modulation of promoter recruitment and transcriptional activity of PPARgamma. Biochem Biophys Res Commun (2007) 1.23

Differential signaling by splice variants of the human free fatty acid receptor GPR120. Mol Pharmacol (2012) 1.13

Pioglitazone increases apolipoprotein A-I production by directly enhancing PPRE-dependent transcription in HepG2 cells. J Lipid Res (2010) 1.11

Pioglitazone attenuates mitochondrial dysfunction, cognitive impairment, cortical tissue loss, and inflammation following traumatic brain injury. Exp Neurol (2010) 1.04

PPARgamma and its ligands: therapeutic implications in cardiovascular disease. Clin Sci (Lond) (2009) 1.03

Inhibition of MMP-9 expression by PPARgamma activators in human bronchial epithelial cells. Thorax (2003) 0.97

Peroxisome proliferator-activated receptors α and γ are linked with alcohol consumption in mice and withdrawal and dependence in humans. Alcohol Clin Exp Res (2014) 0.95

The dual PPARalpha/gamma agonist, ragaglitazar, improves insulin sensitivity and metabolic profile equally with pioglitazone in diabetic and dietary obese ZDF rats. Br J Pharmacol (2005) 0.95

Fatty acids regulate endothelial lipase and inflammatory markers in macrophages and in mouse aorta: a role for PPARγ. Arterioscler Thromb Vasc Biol (2012) 0.93

Beneficial effects of troglitazone on neutrophil dysfunction in multiple low-dose streptozotocin-induced diabetic mice. Clin Exp Immunol (2004) 0.85

PPARβ/δ and PPARγ maintain undifferentiated phenotypes of mouse adult neural precursor cells from the subventricular zone. Front Cell Neurosci (2015) 0.85

Ω-3 fatty acids prevent hepatic steatosis, independent of PPAR-α activity, in a murine model of parenteral nutrition-associated liver disease. JPEN J Parenter Enteral Nutr (2013) 0.83

Peroxisome proliferator-activated receptor ligand MCC-555 suppresses intestinal polyps in ApcMin/+ mice via extracellular signal-regulated kinase and peroxisome proliferator-activated receptor-dependent pathways. Mol Cancer Ther (2008) 0.83

Beneficial effects of thiazolidinediones on diabetic nephropathy in OLETF rats. Yonsei Med J (2007) 0.82

PPAR agonists as therapeutics for CNS trauma and neurological diseases. ASN Neuro (2013) 0.82

PPAR-gamma activation fails to provide myocardial protection in ischemia and reperfusion in pigs. Am J Physiol Heart Circ Physiol (2004) 0.82

Idealized PPARγ-Based Therapies: Lessons from Bench and Bedside. PPAR Res (2012) 0.80

Broad-spectrum neuroprotection against traumatic brain injury by agonism of peroxisome proliferator-activated receptors. Exp Neurol (2011) 0.80

Phytol/Phytanic acid and insulin resistance: potential role of phytanic acid proven by docking simulation and modulation of biochemical alterations. PLoS One (2013) 0.80

Peroxisome proliferator-activated receptors and hepatitis C virus. Therap Adv Gastroenterol (2011) 0.79

Therapeutic Potential of PPARγ Activation in Stroke. PPAR Res (2008) 0.78

MBX-102/JNJ39659100, a novel non-TZD selective partial PPAR-γ agonist lowers triglyceride independently of PPAR-α activation. PPAR Res (2009) 0.78

PPARs and Mitochondrial Metabolism: From NAFLD to HCC. PPAR Res (2016) 0.77

Activation of the retinoid X receptor modulates angiotensin II-induced smooth muscle gene expression and inflammation in vascular smooth muscle cells. Mol Pharmacol (2014) 0.77

Peroxisome-proliferator-activated receptors and the control of levels of prostaglandin-endoperoxide synthase 2 by arachidonic acid in the bovine uterus. Biochem J (2007) 0.76

In Vitro and In Vivo Characterizations of Chiglitazar, a Newly Identified PPAR Pan-Agonist. PPAR Res (2012) 0.76

Peroxisome proliferator-activated receptor agonists: do they increase cardiovascular risk? PPAR Res (2009) 0.76

Thiazolidinediones for nonalcoholic steatohepatitis: A meta-analysis of randomized clinical trials. Medicine (Baltimore) (2016) 0.76

Effect of rosiglitazone on HDL metabolism in subjects with metabolic syndrome and low HDL. J Lipid Res (2010) 0.75

A phase II clinical trial to investigate the effect of pioglitazone on (18)F-FDG uptake in malignant lesions. EJNMMI Res (2015) 0.75

Characterization of pioglitazone cyclodextrin complexes: Molecular modeling to in vivo evaluation. J Pharm Bioallied Sci (2016) 0.75

Distinct but complementary contributions of PPAR isotypes to energy homeostasis. J Clin Invest (2017) 0.75

Three-dimensional perfused human in vitro model of non-alcoholic fatty liver disease. World J Gastroenterol (2017) 0.75

Effect of Leptin Administration on Circulating Apolipoprotein CIII levels in Patients With Lipodystrophy. J Clin Endocrinol Metab (2016) 0.75

Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesis. Oncotarget (2016) 0.75

The possible role of peroxisome proliferator-activated receptor gamma in heart failure. Exp Clin Cardiol (2004) 0.75

PPARdelta Agonism for the Treatment of Obesity and Associated Disorders: Challenges and Opportunities. PPAR Res (2008) 0.75

Synthesis, activity, and docking study of phenylthiazole acids as potential agonists of PPARγ. Drug Des Devel Ther (2016) 0.75

The effect of pioglitazone on aldosterone and cortisol production in HAC15 human adrenocortical carcinoma cells. Mol Cell Endocrinol (2014) 0.75

Peroxisome proliferator-activated receptor gamma activation counters the detrimental effect of Helicobacter pylori lipopolysaccharide on gastric mucin synthesis. Inflammopharmacology (2003) 0.75

Articles by these authors

Cultures in chimpanzees. Nature (1999) 13.33

The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci (1996) 6.04

Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol (1992) 5.93

Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science (1988) 5.56

The 5'-terminal sequence of the hepatitis C virus genome. Jpn J Exp Med (1990) 5.46

Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates for conserved and divergent regions. J Gen Virol (1991) 5.03

The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun (1997) 4.93

A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. Proc Natl Acad Sci U S A (1999) 4.46

T-lymphocyte entry into the central nervous system. J Neurosci Res (1991) 4.28

The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas. Cancer (1999) 3.47

Characterization of Rose Bengal binding to sinusoidal and bile canalicular plasma membrane from rat liver. Biochim Biophys Acta (1989) 3.47

Calculation of child and adult standard liver volume for liver transplantation. Hepatology (1995) 3.33

A revision of Rhizobium Frank 1889, with an emended description of the genus, and the inclusion of all species of Agrobacterium Conn 1942 and Allorhizobium undicola de Lajudie et al. 1998 as new combinations: Rhizobium radiobacter, R. rhizogenes, R. rubi, R. undicola and R. vitis. Int J Syst Evol Microbiol (2001) 2.97

Post-traumatic proliferative vitreoretinopathy. The epidemiologic profile, onset, risk factors, and visual outcome. Ophthalmology (1997) 2.94

Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5'-noncoding region. Jpn J Exp Med (1990) 2.72

Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J Neurochem (1997) 2.62

Secretion cloning vectors in Escherichia coli. EMBO J (1984) 2.58

Production and characterization of monoclonal antibodies specific to multi-ubiquitin chains of polyubiquitinated proteins. FEBS Lett (1994) 2.44

Guanylate cyclase: activation by azide, nitro compounds, nitric oxide, and hydroxyl radical and inhibition by hemoglobin and myoglobin. Adv Cyclic Nucleotide Res (1978) 2.43

Ampulla cardiomyopathy ('Takotusbo' cardiomyopathy)--reversible left ventricular dysfunction: with ST segment elevation. Jpn Circ J (2000) 2.39

Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience (1992) 2.38

Evolutionary adaptation of plasmid-encoded enzymes for degrading nylon oligomers. Nature (1984) 2.29

Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008. Ann Oncol (2009) 2.20

Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes. Diabetes (1999) 2.19

A detailed linkage map of medaka, Oryzias latipes: comparative genomics and genome evolution. Genetics (2000) 2.19

PAR-6 regulates aPKC activity in a novel way and mediates cell-cell contact-induced formation of the epithelial junctional complex. Genes Cells (2001) 2.13

Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy. Int J Cancer (2001) 2.10

Involvement of 14-3-3 proteins in nuclear localization of telomerase. EMBO J (2000) 2.05

Expression and function of the ST2 gene in a murine model of allergic airway inflammation. Clin Exp Allergy (2002) 2.02

Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. Am J Respir Crit Care Med (2001) 2.02

alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A beta-amyloid-induced neurotoxicity. J Biol Chem (2001) 1.93

Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer. Cancer Res (1991) 1.92

Surgical techniques and innovations in living related liver transplantation. Ann Surg (1993) 1.88

Quantitative analysis of cytomegalovirus load using a real-time PCR assay. J Med Virol (2000) 1.84

A novel integrin-linked kinase-binding protein, affixin, is involved in the early stage of cell-substrate interaction. J Cell Biol (2001) 1.84

Evolution of the archaeal rhodopsins: evolution rate changes by gene duplication and functional differentiation. J Mol Biol (1999) 1.83

Sciatic nerve regeneration in rats induced by transplantation of in vitro differentiated bone-marrow stromal cells. Eur J Neurosci (2001) 1.82

Demonstration of a unique population of neurons with NADPH-diaphorase histochemistry. J Neurosci Methods (1983) 1.81

Direct imaging of DNA in living cells reveals the dynamics of chromosome formation. J Cell Biol (1999) 1.81

Activation of guanylate cyclase from rat liver and other tissues by sodium azide. J Biol Chem (1975) 1.77

Atypical adenomatous hyperplasia and bronchoalveolar lung carcinoma. Analysis by morphometry and the expressions of p53 and carcinoembryonic antigen. Am J Surg Pathol (1996) 1.77

Prediction of pharmacokinetic alterations caused by drug-drug interactions: metabolic interaction in the liver. Pharmacol Rev (1998) 1.76

Biochemical function of mouse minichromosome maintenance 2 protein. J Biol Chem (1998) 1.74

Chemical and immunological studies on mycobacterial polysaccharides. 1. Purification and properties of polysaccharides from human tubercle bacilli. J Bacteriol (1968) 1.74

Genetic analyses of GII.17 norovirus strains in diarrheal disease outbreaks from December 2014 to March 2015 in Japan reveal a novel polymerase sequence and amino acid substitutions in the capsid region. Euro Surveill (2015) 1.73

Population dynamics of Japanese monkeys with special reference to the effect of artificial feeding. Folia Primatol (Basel) (1982) 1.73

Human interleukin 6 is a direct promoter of maturation of megakaryocytes in vitro. Proc Natl Acad Sci U S A (1989) 1.69

Evidence for two different forms of guanylate cyclase in rat heart. J Biol Chem (1974) 1.68

Portal tumor thrombus due to gastrointestinal cancer. Abdom Imaging (1999) 1.67

Remitting seronegative symmetrical synovitis with pitting edema associated with gastric carcinoma. J Rheumatol (1997) 1.64

Amyloid peptides are toxic via a common oxidative mechanism. Proc Natl Acad Sci U S A (1995) 1.60

Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta. J Biol Chem (2000) 1.60

Human heart-type cytoplasmic fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction. Clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB. Clin Chem Lab Med (2000) 1.60

Visualization of detailed acetylcholinesterase fiber and neuron staining in rat brain by a sensitive histochemical procedure. J Histochem Cytochem (1986) 1.58

Identification and quantitation of T lymphocyte subsets found in the spinal cord of the Lewis rat during acute experimental allergic encephalomyelitis. J Immunol (1983) 1.58

Increased glucose metabolism and insulin sensitivity in transgenic skinny mice overexpressing leptin. Diabetes (1999) 1.55

Effect of heat stress on muscle sympathetic nerve activity in humans. J Auton Nerv Syst (1997) 1.55

Clinical manifestations of primary herpes simplex virus type 1 infection in a closed community. Pediatrics (1991) 1.55

Clinical development and review times for new drugs in Japan: associated factors. Clin Pharmacol Ther (2010) 1.54

Molecular size and shape of beta-connectin, an elastic protein of striated muscle. J Biochem (1984) 1.53

[A case of colon cancer with tension pneumothorax and empyema as a consequence of colo-pleural fistula]. Nihon Kokyuki Gakkai Zasshi (2000) 1.53

Extensible and less-extensible domains of connectin filaments in stretched vertebrate skeletal muscle sarcomeres as detected by immunofluorescence and immunoelectron microscopy using monoclonal antibodies. J Biochem (1988) 1.53

Long-circulating poly(ethylene glycol)-poly(D,L-lactide) block copolymer micelles with modulated surface charge. J Control Release (2001) 1.52

Reconstruction of the medial patellofemoral ligament for the treatment of habitual or recurrent dislocation of the patella in children. J Bone Joint Surg Br (2003) 1.50

Inhibition of experimental proliferative vitreoretinopathy by retroviral vector-mediated transfer of suicide gene. Can proliferative vitreoretinopathy be a target of gene therapy? Ophthalmology (1995) 1.50

Plasmid-determined enzymatic degradation of nylon oligomers. J Bacteriol (1983) 1.50

Multidrug resistant Mycobacterium leprae from patients with leprosy. Antimicrob Agents Chemother (2001) 1.50

Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain. J Biol Chem (1999) 1.48

[Clinical effects of low-dose long-term erythromycin chemotherapy on diffuse panbronchiolitis]. Nihon Kyobu Shikkan Gakkai Zasshi (1987) 1.48

Tie2-mediated loss of peroxisome proliferator-activated receptor-gamma in mice causes PDGF receptor-beta-dependent pulmonary arterial muscularization. Am J Physiol Lung Cell Mol Physiol (2009) 1.47

Caveolae in mesangial cells and caveolin expression in mesangial proliferative glomerulonephritis. Kidney Int (2001) 1.47

Basement membrane heparan sulfate proteoglycans are concentrated in the laminae rarae and in podocytes of the rat renal glomerulus. Proc Natl Acad Sci U S A (1985) 1.46

Evaluation of brain metabolism in steno-occlusive carotid artery disease by proton MR spectroscopy: a correlative study with oxygen metabolism by PET. J Nucl Med (2000) 1.46

Cyclosporine-induced autoimmunity. Conditions for expressing disease, requirement for intact thymus, and potency estimates of autoimmune lymphocytes in drug-treated rats. J Exp Med (1986) 1.46

Binding of human minichromosome maintenance proteins with histone H3. J Biol Chem (1996) 1.45

Real-time quantitative reverse transcription-polymerase chain reaction for the detection of AML1-MTG8 fusion transcripts in t(8;21)-positive acute myelogenous leukemia. Leuk Res (2000) 1.45

N-methylnicotinamide is an endogenous probe for evaluation of drug-drug interactions involving multidrug and toxin extrusions (MATE1 and MATE2-K). Clin Pharmacol Ther (2012) 1.45

Perivascular location and phenotypic heterogeneity of microglial cells in the rat brain. J Neuroimmunol (1990) 1.45

Gender difference in age-related changes in muscle sympathetic nerve activity in healthy subjects. Am J Physiol (1998) 1.44

Vitamin E succinate inhibits proliferation and migration of retinal pigment epithelial cells in vitro: therapeutic implication for proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol (1996) 1.43

The central cholinergic system studied by choline acetyltransferase immunohistochemistry in the cat. J Comp Neurol (1981) 1.42

Efficient identification of HLA-A*2402-restricted cytomegalovirus-specific CD8(+) T-cell epitopes by a computer algorithm and an enzyme-linked immunospot assay. Blood (2001) 1.42

Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome. Br J Dermatol (2007) 1.42

Dynamics of annular bright field imaging in scanning transmission electron microscopy. Ultramicroscopy (2010) 1.42

Nonenzymatic formation of guanosine 3':5'-monophosphate from guanosine triphosphate. J Biol Chem (1974) 1.42

The XAFS beamline BL01B1 at SPring-8. J Synchrotron Radiat (1999) 1.41

Quantitative analysis of Le(a) and Le(b) antigens in human saliva. Vox Sang (1994) 1.41

Interleukin-6 is a potent thrombopoietic factor in vivo in mice. Blood (1989) 1.40

ApoA-I knockout mice: characterization of HDL metabolism in homozygotes and identification of a post-RNA mechanism of apoA-I up-regulation in heterozygotes. J Lipid Res (1997) 1.39

High prevalence of serum apolipoprotein E4 isoprotein in rheumatoid arthritis patients with amyloidosis. Arthritis Rheum (1996) 1.39

Respiration effect of synthetic progestin in small doses in normal men. Chest (1989) 1.39

Missense mutation of FUT1 and deletion of FUT2 are responsible for Indian Bombay phenotype of ABO blood group system. Biochem Biophys Res Commun (1997) 1.39

The efferent projections of the rat lateral habenular nucleus revealed by the PHA-L anterograde tracing method. Brain Res (1988) 1.39

Isolation and characterization of mini-Tn5Km2 insertion mutants of enterohemorrhagic Escherichia coli O157:H7 deficient in adherence to Caco-2 cells. Infect Immun (2000) 1.39

Microvascular studies on the origins of perfusion-limited hypoxia. Br J Cancer Suppl (1996) 1.38

Effects of propofol on isolated rabbit mesenteric arteries and veins. Br J Anaesth (1995) 1.38

Thyrotropin secreting pituitary adenoma effectively treated with octreotide. Intern Med (1998) 1.38

A sphincterotome with variable-length wire for easier endoscopic sphincterotomy and quicker biliary drainage. Gastrointest Endosc (1995) 1.38

Surgical treatment of patients with congenital vascular malformation-associated aneurysms. Eur J Vasc Endovasc Surg (2011) 1.38